RGNCY-0096 (CS-11 PP2A–β-Catenin inhibitor)
SOLD OUT!! E-mail us at info@reagency.co if you are interested in this product.
CS-11 is a novel inhibitor of PP2A–β-Catenin signalling that limits both in vivo tumor growth and metastases. By inhibiting PP2A and β-Catenin interaction, Cs-11diminishes the expression of active β-Catenin and its target proteins c-Myc and Cyclin D1. It also promotes E-Cadherin upregulation on the cell surface and increases β-Catenin and E-Cadherin association that may prevent metastases.
Systematic Name: 2-((E)-2-hydroxy-3-isopropyl-5-((E)-3-oxo-3-(p-tolyl)prop-1-en-1-yl)benzylidene)-N-phenylhydrazine-1-carboxamide
SMILES: CC(C)C1=CC(/C=C/C(C2=CC=C(C)C=C2)=O)=CC(/C=N/NC(NC3=CC=CC=C3)
=O)=C1O
Formula: C27H27N3O3
Mol Wt: 441.53
PMID: 28500231
Tags: Cancer, beta-catenin, small molecule, breast cancer, CYCLIN D1, MCF-7, c-Myc, MCF-10A, CS-11, RGNCY-0096, PP2A–β-Catenin, PP2A, E-Cadherin